BIONEXUS GENE LAB CORP (BGLC)
US0906282076 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -942.60K | -2.63M | -360.00K | 750.00K | 1.09M | |||
| Depreciation Amortization | 94.71K | 83.25K | 90.00K | 90.00K | 90.00K | |||
| Change In Working Capital | -310.72K | 117.98K | 830.00K | -860.00K | 100.00K | |||
| Interest Paid | 19.51K | 13.93K | 10.00K | 10.00K | 10.00K | |||
| Taxes Paid | 59.00K | 66.97K | 170.00K | 230.00K | 130.00K | |||
| Other non cash items | -1.27M | 1.13M | -20.00K | 30.00K | -730.00K | |||
| OPERATING CASH FLOW | -2.43M | -1.30M | 540.00K | 10.00K | 550.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -223.91K | -149.40K | -50.00K | 0.00 | -420.00K | |||
| Other Investing Activity | 134.19K | -233.18K | -400.00K | -490.00K | 1.74M | |||
| INVESTING CASH FLOW | -89.72K | -382.58K | -450.00K | -490.00K | 1.32M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -30.00K | -30.00K | 0.00 | |||
| Stock Issued/Repurchased | N/A | 5.75M | 150.00K | N/A | 0.00 | |||
| Other Financing Activity | 9.50K | 4.32K | 0.00 | 0.00 | 0.00 | |||
| FINANCING CASH FLOW | 9.50K | 5.75M | 120.00K | -30.00K | 0.00 | |||
| Exchange Rate Effect | 496.94K | -259.68K | -210.00K | -150.00K | 60.00K | |||
| CHANGE IN CASH | -2.01M | 3.81M | 0.00 | -660.00K | 1.93M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -2.43M | -1.30M | 540.00K | 10.00K | 550.00K | |||
| Capital Expenditure | -223.91K | -149.40K | -50.00K | 0.00 | -420.00K | |||
| FREE CASH FLOW | -2.65M | -1.45M | 490.00K | 10.00K | 130.00K | |||
All data in USD